Restart Life Sciences Corp. (CSE:HEAL)

Canada flag Canada · Delayed Price · Currency is CAD
0.110
+0.015 (15.79%)
Feb 21, 2025, 4:00 PM EST
-26.67%
Market Cap 1.99M
Revenue (ttm) -28.35K
Net Income (ttm) 15.05K
Shares Out 18.13M
EPS (ttm) -0.00
PE Ratio 132.50
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 45,600
Average Volume 35,380
Open 0.110
Previous Close 0.095
Day's Range 0.110 - 0.120
52-Week Range 0.030 - 0.200
Beta 0.82
RSI 62.67
Earnings Date Apr 8, 2025

About Restart Life Sciences

Restart Life Sciences Corp., through its subsidiaries, operates as a biotechnology company worldwide. It engages in developing diagnostics and psilocybin-based therapeutics for the treatment of neuroinflammatory disorders, including autism spectrum disorder and fragile X syndrome. The company was formerly known as Nova Mentis Life Science Corp. and changed its name to Restart Life Sciences Corp. in November 2024. Restart Life Sciences Corp. was incorporated in 2004 and is based in Vancouver, Canada. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2004
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol HEAL
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.